a
a
Weather:
No weather information available
HomeHealthMedtronic to separate diabetes business into standalone company

Medtronic to separate diabetes business into standalone company

The spin off is expected to be complete within the next 18 months through a series of capital markets deals, with a preferred path of an initial public offering and subsequent split-off.
No comments

Sorry, the comment form is closed at this time.

Translate »